Cross-priming underlies the efficacy of antibody–drug conjugates and immunotherapy combinations
- DOI
- 10.1016/j.it.2026.06.003
- Published
- 2026-06
- Container
- Trends in Immunology
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.it.2026.06.003,
title = {Cross-priming underlies the efficacy of antibody–drug conjugates and immunotherapy combinations},
author = {Gabriel Gomis and Pedro Berraondo and Claudia Herrero and Carlos Luri-Rey and Ignacio Melero},
year = {2026},
journal = {Trends in Immunology},
doi = {10.1016/j.it.2026.06.003},
url = {https://doi.org/10.1016/j.it.2026.06.003}
}RIS
TY - JOUR TI - Cross-priming underlies the efficacy of antibody–drug conjugates and immunotherapy combinations AU - Gabriel Gomis AU - Pedro Berraondo AU - Claudia Herrero AU - Carlos Luri-Rey AU - Ignacio Melero PY - 2026 JO - Trends in Immunology DO - 10.1016/j.it.2026.06.003 UR - https://doi.org/10.1016/j.it.2026.06.003 ER -
APA
Gomis, G., Berraondo, P., Herrero, C., Luri-Rey, C., & Melero, I. (2026). Cross-priming underlies the efficacy of antibody–drug conjugates and immunotherapy combinations. Trends in Immunology. https://doi.org/10.1016/j.it.2026.06.003
Source records
- crossref · retrieved 2026-09-27T00:14:32.604Z